Postdoctoral Scientist
Applications for this vacancy closed on 7 April 2025 at 12:00PM
We are seeking a Postdoctoral Scientist. The appointee will interact with
clinicians as well as non-clinical scientists across the campus in Oxford,
with the team at Ludger Ltd as well as with international partners in the
Intercept consortium. The focus is on the discovery of glycomic biomarkers to
be used in the early pre-symptomatic diagnosis of the chronic inflammatory
bowel diseases, Crohn’s disease and ulcerative colitis.
The post arises as the latest element in an on-going research programme aimed
at understanding the pathogenesis of inflammatory bowel disease, and in
stratifying the care of patients with inflammatory bowel disease. Biomarker
discovery by the application of multi-omics has been a focus of our teams’
work for over a decade, and this post builds on a series of previous studies,
notably with collaborations between Oxford, international clinical partners,
and the biotechnology industry. The collaboration with Ludger Ltd has been
productive in helping define the circulating glycome in disease, and
biomarkers of severe ulcerative colitis.
The INTERCEPT consortium (intercept-ihi.eu) is co-funded (38.05m Euro in
total) by the European Community & industrial partners and represents an
ambitious cutting edge study to define biomarkers accurate for pre-symptomatic
diagnosis in Crohn’s disease and to use these as the basis of early treatment
intervention to either prevent disease, or reduce disease severity. The post
holder is a member of research groups with responsibility for carrying out
translational research in inflammatory bowel disease. The post holder will
work with non-clinical and clinical scientists in Oxford, in Ludger and in the
collaborating centres. The post holder provides guidance to less experienced
members of the research group, including postdocs, research assistants,
technicians, and PhD and project students.
The post holder will ideally be able to combine bioinformatics and laboratory
responsibilities, and will have received training as necessary in this. It
will be a great advantage if the post holder is able to bring relevant skills
to the post. The post holder would need to have laboratory skills in
analytical method development, specifically in HPLC and mass spectrometry
based (electrospray type MS) separation and detection techniques. Ideally, but
not essential, is familiarity with the scientific field of glycoscience.
It is essential to hold a relevant PhD/DPhil in a relevant scientific
discipline such as genetics/cell biology/biochemistry/immunology. You will
possess sufficient specialist knowledge in the discipline to work within
established research programmes.
The post is full time and fixed term for up to 12 months in the first
instance.
Applications for this vacancy are to be made online. You will be required to
upload a supporting statement and CV as part of your online application.
Only applications received before 12:00 midday on 07/04/2025 will be
considered.
clinicians as well as non-clinical scientists across the campus in Oxford,
with the team at Ludger Ltd as well as with international partners in the
Intercept consortium. The focus is on the discovery of glycomic biomarkers to
be used in the early pre-symptomatic diagnosis of the chronic inflammatory
bowel diseases, Crohn’s disease and ulcerative colitis.
The post arises as the latest element in an on-going research programme aimed
at understanding the pathogenesis of inflammatory bowel disease, and in
stratifying the care of patients with inflammatory bowel disease. Biomarker
discovery by the application of multi-omics has been a focus of our teams’
work for over a decade, and this post builds on a series of previous studies,
notably with collaborations between Oxford, international clinical partners,
and the biotechnology industry. The collaboration with Ludger Ltd has been
productive in helping define the circulating glycome in disease, and
biomarkers of severe ulcerative colitis.
The INTERCEPT consortium (intercept-ihi.eu) is co-funded (38.05m Euro in
total) by the European Community & industrial partners and represents an
ambitious cutting edge study to define biomarkers accurate for pre-symptomatic
diagnosis in Crohn’s disease and to use these as the basis of early treatment
intervention to either prevent disease, or reduce disease severity. The post
holder is a member of research groups with responsibility for carrying out
translational research in inflammatory bowel disease. The post holder will
work with non-clinical and clinical scientists in Oxford, in Ludger and in the
collaborating centres. The post holder provides guidance to less experienced
members of the research group, including postdocs, research assistants,
technicians, and PhD and project students.
The post holder will ideally be able to combine bioinformatics and laboratory
responsibilities, and will have received training as necessary in this. It
will be a great advantage if the post holder is able to bring relevant skills
to the post. The post holder would need to have laboratory skills in
analytical method development, specifically in HPLC and mass spectrometry
based (electrospray type MS) separation and detection techniques. Ideally, but
not essential, is familiarity with the scientific field of glycoscience.
It is essential to hold a relevant PhD/DPhil in a relevant scientific
discipline such as genetics/cell biology/biochemistry/immunology. You will
possess sufficient specialist knowledge in the discipline to work within
established research programmes.
The post is full time and fixed term for up to 12 months in the first
instance.
Applications for this vacancy are to be made online. You will be required to
upload a supporting statement and CV as part of your online application.
Only applications received before 12:00 midday on 07/04/2025 will be
considered.
dc:spatial |
Translational Gastroenterology Unit, JR Hospital, Headington, Oxford, OX3 9DU
|
---|---|
Subject | |
oo:contact | |
oo:formalOrganization | |
oo:organizationPart | |
vacancy:applicationClosingDate |
2025-04-07 12:00:00+01:00
|
vacancy:applicationOpeningDate |
2025-03-10 09:45:00+00:00
|
vacancy:internalApplicationsOnly |
False
|
vacancy:salary | |
type | |
comment |
We are seeking a Postdoctoral Scientist. The appointee will interact with
clinicians as well as non-clinical scientists across the campus in Oxford, with the team at Ludger Ltd as well as with international partners in the Intercept consortium. The focus is on the discovery of glycomic biomarkers to be used in the early pre-symptomatic diagnosis of the chronic inflammatory bowel diseases, Crohn’s disease and ulcerative colitis. The post arises as the latest element in an on-going research programme aimed at understanding the pathogenesis of inflammatory bowel disease, and in stratifying the care of patients with inflammatory bowel disease. Biomarker discovery ... We are seeking a Postdoctoral Scientist. The appointee will interact with clinicians as well as non-clinical scientists across the campus in Oxford, with the team at Ludger Ltd as well as with international partners in the Intercept consortium. The focus is on the discovery of glycomic biomarkers to be used in the early pre-symptomatic diagnosis of the chronic inflammatory bowel diseases, Crohn’s disease and ulcerative colitis. The post arises as the latest element in an on-going research programme aimed at understanding the pathogenesis of inflammatory bowel disease, and in stratifying the care of patients with inflammatory bowel disease. Biomarker ... |
label |
Postdoctoral Scientist
|
notation |
178563
|
based near |